Literature DB >> 19902397

[Complications of uveitis: prevalence and risk factors in a series of 398 cases].

M Prieto-del-Cura1, J González-Guijarro.   

Abstract

OBJECTIVE: To estimate the rate of complications and establish risk factors for their development in patients with uveitis.
METHODS: Prospective study of a cohort of 398 patients (413 eyes) that were reviewed from January 2000 to October 2007 and monitored during a period of at least one month. Demographic data, laterality, course (acute, subacute, chronic), location, diagnosis (idiopathic, infectious, ocular origin, systemic origin, others) and development of complications (cataract, cystoid macular edema, macular complications, retinal complications and others) were evaluated.
RESULTS: After a mean follow-up of 35.2 months (range 1-160), 25% of patients developed one or more of the following complications: cataract 8.5%, macular edema 6.1%, macular complications (epiretinal membranes, choroidal neovascular membranes, macular necrosis) 4.1%, retinal complications (retinal detachment, retinal neovascularization, vitreous hemorrhage, retinal tears, retinal vascular occlusions) 4.1%, glaucoma or ocular hypertension 3.6%, and others 1.5%. Risk factors for development of uveitis complications were chronic course OR 6.37 (3.25-12.47) P <0.0001, bilaterality OR 1.98 (1.03-3.08) P =0.039, subacute course OR 1.94 (0.02-4.08) P=0.08, and panuveitis OR 1,92 (0.99-4.80) P=0.161.
CONCLUSIONS: In our patients, cases involving chronic and bilateral uveitis were more prone to develop complications, with cataracts being the most frequent complication (Arch Soc Esp Oftalmol 2009; 84: 523-528).

Entities:  

Mesh:

Year:  2009        PMID: 19902397     DOI: 10.4321/s0365-66912009001000007

Source DB:  PubMed          Journal:  Arch Soc Esp Oftalmol        ISSN: 0365-6691


  5 in total

Review 1.  Mitochondrial oxidative stress initiates visual loss in sympathetic ophthalmia.

Authors:  Yutaka Kaneko; Narsing A Rao
Journal:  Jpn J Ophthalmol       Date:  2012-04-03       Impact factor: 2.447

2.  Systemic contribution of inflammatory mediators to the severity of diabetic and uveitic macular edema.

Authors:  Marc Figueras-Roca; Jessica Matas; Víctor Llorens; Anna Sala-Puigdollers; Manuel Navarro; Javier Zarranz-Ventura; Alfredo Adán; Blanca Molins
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-03-12       Impact factor: 3.117

3.  Protocol: Effect of intravitreal bevacizumab (avastin) in the treatment of macular edema: A systematic review of randomized controlled trials.

Authors:  Hammad A Qazi
Journal:  J Res Med Sci       Date:  2012-12       Impact factor: 1.852

4.  Predictors for functional and anatomic outcomes in macular edema secondary to non-infectious uveitis.

Authors:  Jessica Matas; Victor Llorenç; Alex Fonollosa; Cristina Esquinas; David Diaz-Valle; Barbara Berasategui; Marina Mesquida; Joseba Artaraz; Jose Rios; Alfredo Adan
Journal:  PLoS One       Date:  2019-01-24       Impact factor: 3.240

5.  New insights into cataract surgery in patients with uveitis: A detailed review of the current literature.

Authors:  Rakan S Al-Essa; Abdullah M Alfawaz
Journal:  Saudi J Ophthalmol       Date:  2022-02-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.